SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

doi:10.1016/j.ebiom.2021.103401

. 2021 Jun:68:103401.

doi: 10.1016/j.ebiom.2021.103401. Epub 2021 May 26.

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman¹, Anthony D Harris², Ramin Sedaghat Herati³, Florian Krammer⁴, Alberto Mantovani⁵, Maria Rescigno⁶, Mohammad M Sajadi⁷, Viviana Simon⁸

Affiliations

¹ Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States. Electronic address: MFrieman@som.umaryland.edu.
² Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States. Electronic address: aharris@som.umaryland.edu.
³ New York University School of Medicine, New York City, NY, United States. Electronic address: Ramin.Herati@nyulangone.org.
⁴ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: florian.krammer@mssm.edu.
⁵ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy; The William Harvey Research Institute, Queen Mary University, London, United Kingdom. Electronic address: Alberto.Mantovani@humanitasresearch.it.
⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy. Electronic address: maria.rescigno@hunimed.eu.
⁷ Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States; Global Virus Network, Baltimore, Maryland, United States. Electronic address: msajadi@ihv.umaryland.edu.
⁸ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: viviana.simon@mssm.edu.

PMID: 34051441
PMCID: PMC8149267
DOI: 10.1016/j.ebiom.2021.103401

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman et al. EBioMedicine. 2021 Jun.

. 2021 Jun:68:103401.

doi: 10.1016/j.ebiom.2021.103401. Epub 2021 May 26.

Authors

Matthew Frieman¹, Anthony D Harris², Ramin Sedaghat Herati³, Florian Krammer⁴, Alberto Mantovani⁵, Maria Rescigno⁶, Mohammad M Sajadi⁷, Viviana Simon⁸

Affiliations

¹ Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States. Electronic address: MFrieman@som.umaryland.edu.
² Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States. Electronic address: aharris@som.umaryland.edu.
³ New York University School of Medicine, New York City, NY, United States. Electronic address: Ramin.Herati@nyulangone.org.
⁴ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: florian.krammer@mssm.edu.
⁵ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy; The William Harvey Research Institute, Queen Mary University, London, United Kingdom. Electronic address: Alberto.Mantovani@humanitasresearch.it.
⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy. Electronic address: maria.rescigno@hunimed.eu.
⁷ Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States; Global Virus Network, Baltimore, Maryland, United States. Electronic address: msajadi@ihv.umaryland.edu.
⁸ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: viviana.simon@mssm.edu.

PMID: 34051441
PMCID: PMC8149267
DOI: 10.1016/j.ebiom.2021.103401

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Matthew Frieman, Anthony D. Harris, Ramin Sedaghat Herati, and Mohammad M. Sajadi have nothing to disclose. The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 95 serological assays and NDV-based SARS-CoV-2 vaccines which list Florian Krammer as co-inventor (US Provisional Application No 62/994,252). Viviana Simon is also listed on the serological assay patent application as co-inventor (US Provisional Application No 62/994,252). Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. Florian Krammer has consulted for Merck and Pfizer (before 2020), and is currently consulting for Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. Alberto Mantovani has consulted for Pfizer and Astra Zeneca. Maria Rescigno serves as a consultant for DiaSorin and Gelesis. Diasorin supports Humanitas for the development of diagnostic assays related to COVID-19 and has filed patent applications with Alberto Mantovani as co-inventor.

Cited by

Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021.
Ossato A, Tessari R, Trabucchi C, Zuppini T, Realdon N, Marchesini F. Ossato A, et al. Eur J Hosp Pharm. 2023 Jul;30(4):e15. doi: 10.1136/ejhpharm-2021-002933. Epub 2021 Jul 27. Eur J Hosp Pharm. 2023. PMID: 34315774 Free PMC article.
PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.
Simon V, Kota V, Bloomquist RF, Hanley HB, Forgacs D, Pahwa S, Pallikkuth S, Miller LG, Schaenman J, Yeaman MR, Manthei D, Wolf J, Gaur AH, Estepp JH, Srivastava K, Carreño JM, Cuevas F; PARIS/SPARTA Study Group,; Ellebedy AH, Gordon A, Valdez R, Cobey S, Reed EF, Kolhe R, Thomas PG, Schultz-Cherry S, Ross TM, Krammer F. Simon V, et al. mSphere. 2022 Jun 29;7(3):e0017922. doi: 10.1128/msphere.00179-22. Epub 2022 May 19. mSphere. 2022. PMID: 35586986 Free PMC article.
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.
Miyakawa K, Jeremiah SS, Kato H, Yamaoka Y, Go H, Yajima S, Shimada T, Mihara T, Goto A, Yamanaka T, Ryo A. Miyakawa K, et al. J Mol Cell Biol. 2022 Jan 29;13(12):918-920. doi: 10.1093/jmcb/mjab050. J Mol Cell Biol. 2022. PMID: 34450642 Free PMC article. No abstract available.
Incidence of SARS-CoV-2 Infection and Factors Associated With Complete COVID-19 Vaccine Uptake Among Migrant Origin Persons in Finland.
Bastola K, Nohynek H, Lilja E, Castaneda AE, Austero S, Kuusio H, Skogberg N. Bastola K, et al. Int J Public Health. 2023 May 3;68:1605547. doi: 10.3389/ijph.2023.1605547. eCollection 2023. Int J Public Health. 2023. PMID: 37206095 Free PMC article.
Short-term side effects of BNT162b2 vaccine in primary care settings in Qatar: a retrospective study.
Abdeen S, Abed Alah M, Al-Zaidan M, Mohamed Ibrahim MI, Abdulmajeed J, Al-Nuaimi AA, Al-Kuwari MG. Abdeen S, et al. Front Public Health. 2024 Apr 10;12:1384327. doi: 10.3389/fpubh.2024.1384327. eCollection 2024. Front Public Health. 2024. PMID: 38660363 Free PMC article.

See all "Cited by" articles

References

1. Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 - PMC - PubMed
1. Saadat S, Tehrani ZR, Logue J, Newman M, Frieman MB, Harris AD. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2. JAMA. 2021 - PMC - PubMed
1. Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021;26(6) - PMC - PubMed
1. Ebinger JE, Fert-Bober J, Printsev I, Wu M, Sun N, John C., Prostko JC. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nature Medicine. 2021;384 - PMC - PubMed
1. Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19. J Clin Invest. 2021 May 6:149154. doi: 10.1172/JCI149154. Online ahead of print.PMID: 33956667 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 - PMC - PubMed

[2] Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med. 2021 - PMC - PubMed

[3] Saadat S, Tehrani ZR, Logue J, Newman M, Frieman MB, Harris AD. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2. JAMA. 2021 - PMC - PubMed

[4] Saadat S, Tehrani ZR, Logue J, Newman M, Frieman MB, Harris AD. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2. JAMA. 2021 - PMC - PubMed

[5] Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021;26(6) - PMC - PubMed

[6] Abu Jabal K, Ben-Amram H, Beiruti K, Batheesh Y, Sussan C, Zarka S. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021. Euro Surveill. 2021;26(6) - PMC - PubMed

[7] Ebinger JE, Fert-Bober J, Printsev I, Wu M, Sun N, John C., Prostko JC. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nature Medicine. 2021;384 - PMC - PubMed

[8] Ebinger JE, Fert-Bober J, Printsev I, Wu M, Sun N, John C., Prostko JC. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nature Medicine. 2021;384 - PMC - PubMed

[9] Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19. J Clin Invest. 2021 May 6:149154. doi: 10.1172/JCI149154. Online ahead of print.PMID: 33956667 - DOI - PMC - PubMed

[10] Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19. J Clin Invest. 2021 May 6:149154. doi: 10.1172/JCI149154. Online ahead of print.PMID: 33956667 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Affiliations

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous